Teladoc Health, Inc. (TDOC) company profile
Close on Nov 17, 2026Market cap $1.55BP/E –Yield –
About Teladoc Health
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
Teladoc Health provides virtual healthcare services that connect patients with medical professionals for remote clinical care. The company operates through two main segments: Integrated Care and BetterHelp. Its Integrated Care segment offers primary care, urgent care, chronic disease management, mental health services, and medical second opinions, alongside telehealth software and connected devices for health systems. Its BetterHelp segment provides online therapy, counseling, and sleep wellness applications. The company serves individual consumers as well as institutional clients, including employers, health plans, hospital networks, and financial institutions.
The organization maintains operations across five continents and utilizes a network of more than 40,000 healthcare providers, including nearly 35,000 licensed clinicians within its mental health platform. In the United States, approximately 102 million individuals have access to its services. The company's international operations are headquartered in Barcelona, Spain, supported by satellite locations in Canada, Europe, South America, Australia, and Asia.
Summary of the business section of Teladoc Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Teladoc Health, Inc.
- Founded
- 2002
- Headquarters
- New York, NY
- Address
- 155 E 44th Street, Suite 1700 10017
- Phone
- (203) 635-2002
- Website
- www.teladoc.com
- Employees
- 5,600, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, New York, New York
Stock & identifiers
- Ticker
- TDOC
- Exchange
- NYSE
- IPO date
- Jun 30, 2015
- Shares outstanding
- 182M, Oct 23, 2026
- Public float
- $1.53B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1477449
- CUSIP
- 87918A105
- ISIN
- US87918A1051
- FIGI
- BBG0019T5SG0
- Share class FIGI
- BBG001TG5PC6
- LEI
- 549300I2PVFBC9MFAC61
- EIN
- 04-3705970
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Charles Divita Iii | CHIEF EXECUTIVE OFFICER, Director | 465,535 |
| Carlos Nueno | President, International | 35,312 |
| Jonathan Dorfman | Chief Legal Officer, Secretary | 2,773 |
| Joseph Ronald Catapano | Chief Accounting Officer | 14,293 |
| Fernando M. Rodrigues | President of BetterHelp | 0 |
| Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 117,616 |
| Kelly Bliss | President, U.S. Group Health | 92,832 |
| Michael F. Grasher | Chief Financial Officer | – |
| Mala Murthy | CHIEF FINANCIAL OFFICER | 142,385 |
| Mark V. Anquillare | Director | – |
| David L. Shedlarz | Director | 61,266 |
| David B. Snow Jr | Director | 165,032 |
| Mark Douglas Smith | Director | 8,355 |
| Kenneth H. Paulus | Director | 10,000 |
| Catherine Jacobson | Director | 66,853 |
| Sandra L. Fenwick | Director | 40,702 |
| Susan R. Salka | Director | – |
| Michael S. Smith | Director | – |
| Jason Eric Evans | Director | 9,145 |
| Thomas McKinley | Director | 57,098 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $11.20M | $5.44M | $3.22M | $4 | $148 |
| FY2024 Divita | $16.06M | $5.30M | $3.22M | $5 | $129 |
| FY2024 Gorevic | $9.37M | -$1.25M | $3.22M | $5 | $129 |
| FY2024 Murthy | $5.23M | -$1.09M | $3.22M | $5 | $129 |
| FY2023 | $11.61M | $9.40M | $4.94M | $11 | $126 |
| FY2022 | $10.88M | -$2.76M | $8.21M | $12 | $124 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Charles Divita, III Chief executive officer | $800.00K | $9.70M | $584.00K | $119.00K | $11.20M | -30% |
| Mala Murthy Former chief financial officer | $489.38K | $3.30M | – | $14.00K | $3.80M | -27% |
| Carlos Nueno President, international | $589.55K | $2.00M | $564.20K | $95.37K | $3.25M | +19% |
| Kelly Bliss President, U.S. group health | $516.67K | $2.10M | $331.50K | $14.00K | $2.96M | +18% |
| Adam C. Vandervoort Chief legal officer and secretary | $495.00K | $2.10M | $247.00K | $14.00K | $2.86M | +8% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed approximately 5,600 people, comprised of approximately 83% full-time employees and 17% part-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 30, 2020 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 3, 2020 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Jul 2, 2020 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 1, 2018 | Name change | Name changed from Teladoc, Inc. to Teladoc Health, Inc. |
| Jun 4, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 18, 2017 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 6, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 26, 2015 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?